andreev-ss 1

1. Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression moderate
2. Artificial intelligence tools for phenotyping patients with anaphylaxis
3. Clinical-anamnestic analysis of patients diagnosed as Anaphylaxis hospitalized in Moscow medical hospitals
4. Clinical and anamnestic analysis of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis hospitalised in Moscow. Development of a prognostic model of unfavourable outcomes
1